Search

everythinglearnresearchcommunity

for

Search:↓

Glucocorticoids can cause various health issues, but some treatments may help reduce these effects.

Androgens can both increase body hair and cause scalp hair loss.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Finasteride helps protect brain in old male rats.

Changing allopregnanolone levels in baby rats affects their adult behavior and alcohol use.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Metformin is less effective in men with early-onset hair loss.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Hidradenitis suppurativa improves with antiandrogen therapy.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

A low-glycemic diet improved hormone levels and well-being in overweight women with high androgen levels.